New Lung Cancer Innovations Offering Hope to Patients
At Memorial Sloan Kettering, cutting-edge lung cancer care is changing lives—especially for those with advanced disease. Take Jen Cosgrove, a mother diagnosed with stage 4 lung cancer that had spread. Thanks to precise testing, doctors found her tumor had an ALK gene mutation, which responds well to targeted therapy called alectinib. Jen saw dramatic improvements within days and has been able to share important milestones with her children she once feared missing. MSK’s expert care, innovative treatments, and thorough diagnostics give patients like Jen hope and more time with their loved ones.
New Discoveries in Lung Cancer Detection
MSK researchers are also uncovering new types of lung cancer and better ways to detect it early. For example, they identified a rare form called atypical small cell lung carcinoma in younger patients who never smoked. Early detection remains critical, and MSK is developing noninvasive tools like the “E-nose,” a device that detects cancer-related chemicals in breath, which could make screening easier and less stressful. Lab studies on lung stem cells and tumor growth help scientists understand how cancer starts and grows, leading to better treatments. For patients facing lung cancer, these advances mean earlier diagnosis, more personalized care, and brighter hope for the future. (Source: Memorial Sloan Kettering)
Read the complete article here >
Resources for Living With Stage 4 Cancer
Learn more about topics like lung cancer innovations. Become a member of our community to gain access to trusted resources, as well as online support and education from Dr. Sharon May, Ph.D., LMFT.
